Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Discovery of a series of novel 2,4-disubstituted arylamides as potential anti-inflammatory agents is described. Compound 8 was utilized in an in vivo CIA model to evaluate the therapeutic potential of FMS inhibition. The optimization of the arylamide lead 2 resulted in identification of a highly pot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-03, Vol.18 (5), p.1642-1648
Hauptverfasser: Illig, Carl R., Chen, Jinsheng, Wall, Mark J., Wilson, Kenneth J., Ballentine, Shelley K., Rudolph, M. Jonathan, DesJarlais, Renee L., Chen, Yanmin, Schubert, Carsten, Petrounia, Ioanna, Crysler, Carl S., Molloy, Christopher J., Chaikin, Margery A., Manthey, Carl L., Player, Mark R., Tomczuk, Bruce E., Meegalla, Sanath K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Discovery of a series of novel 2,4-disubstituted arylamides as potential anti-inflammatory agents is described. Compound 8 was utilized in an in vivo CIA model to evaluate the therapeutic potential of FMS inhibition. The optimization of the arylamide lead 2 resulted in identification of a highly potent series of 2,4-disubstituted arylamides. Compound 8 (FMS kinase IC 50 = 0.0008 μM) served as a proof-of-concept candidate in a collagen-induced model of arthritis in mice.
ISSN:0960-894X
0968-0896
1464-3405
1464-3391
DOI:10.1016/j.bmcl.2008.01.059